Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Catheter Precision (VTAK) Profit After Tax (2017 - 2025)

Catheter Precision (VTAK) has disclosed Profit After Tax for 9 consecutive years, with -$2.3 million as the latest value for Q3 2025.

  • On a quarterly basis, Profit After Tax rose 43.11% to -$2.3 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$17.5 million, a 49.56% decrease, with the full-year FY2024 number at -$16.6 million, up 76.42% from a year prior.
  • Profit After Tax was -$2.3 million for Q3 2025 at Catheter Precision, up from -$5.5 million in the prior quarter.
  • In the past five years, Profit After Tax ranged from a high of -$669000.0 in Q4 2023 to a low of -$66.4 million in Q1 2023.
  • A 5-year average of -$8.2 million and a median of -$5.2 million in 2021 define the central range for Profit After Tax.
  • Peak YoY movement for Profit After Tax: plummeted 1108.37% in 2023, then soared 95.97% in 2024.
  • Catheter Precision's Profit After Tax stood at -$10.5 million in 2021, then rose by 22.13% to -$8.2 million in 2022, then soared by 91.8% to -$669000.0 in 2023, then tumbled by 741.26% to -$5.6 million in 2024, then skyrocketed by 58.35% to -$2.3 million in 2025.
  • Per Business Quant, the three most recent readings for VTAK's Profit After Tax are -$2.3 million (Q3 2025), -$5.5 million (Q2 2025), and -$4.0 million (Q1 2025).